Header Logo

Connection

Noluthando Mwelase to Antitubercular Agents

This is a "connection" page, showing publications Noluthando Mwelase has written about Antitubercular Agents.
Connection Strength

0,252
  1. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. N Engl J Med. 2019 03 14; 380(11):1001-1011.
    View in: PubMed
    Score: 0,129
  2. Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. Clin Infect Dis. 2024 03 20; 78(3):667-673.
    View in: PubMed
    Score: 0,046
  3. Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing. Antimicrob Agents Chemother. 2022 09 20; 66(9):e0238521.
    View in: PubMed
    Score: 0,041
  4. Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention. J Antimicrob Chemother. 2021 02 11; 76(3):718-721.
    View in: PubMed
    Score: 0,037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.